resveratrol has been researched along with kt 5720 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alkhalaf, M; El-Mowafy, AM; Nassar, NN | 1 |
1 other study(ies) available for resveratrol and kt 5720
Article | Year |
---|---|
Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.
Topics: Antineoplastic Agents, Phytogenic; Carbazoles; Cell Division; Cells, Cultured; Coronary Vessels; Cyclic GMP-Dependent Protein Kinases; Drug Interactions; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogens; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Protein Kinase Inhibitors; Pyrroles; Resveratrol; Stilbenes | 2009 |